Medication-Assisted Treatment (MAT): The Gold Standard for Opioid Recovery
FDA-approved medications paired with therapy for a whole-patient approach to opioid and alcohol recovery
What is Medication-Assisted Treatment?
Medication-Assisted Treatment (MAT) combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. This "whole-patient" approach addresses both the physical and psychological aspects of addiction, significantly improving treatment outcomes and reducing the risk of overdose and death.
The Science Behind MAT
MAT works by targeting the brain's opioid receptors—the same receptors affected by drugs like heroin and prescription painkillers. Depending on the medication, MAT can activate these receptors to prevent withdrawal (agonists), partially activate them to reduce cravings (partial agonists), or block them entirely to prevent any effects from opioid use (antagonists).
This pharmacological approach gives the brain time to heal while the patient engages in therapy and rebuilds their life. Unlike simply "replacing one drug with another," MAT medications are carefully dosed to normalize brain chemistry without producing euphoria, allowing patients to function normally while in recovery.
MAT vs MOUD: Understanding the Terminology
You may hear different terms for this treatment approach. MAT (Medication-Assisted Treatment) is the traditional term emphasizing the combination of medication with therapy. MOUD (Medications for Opioid Use Disorder) is a newer term that focuses specifically on the medications for opioid addiction, reflecting current evidence that these medications are effective treatments in their own right, not merely "assistance."
Similarly, MAUD (Medications for Alcohol Use Disorder) refers to FDA-approved medications for alcohol addiction. Regardless of terminology, the evidence is clear: medication combined with behavioral treatment produces the best outcomes.
FDA-Approved Medications for MAT
Three medications are FDA-approved for treating opioid use disorder, and three for alcohol use disorder. Each works differently and is suited to different patients and situations.
Opioid Medications
Buprenorphine (Suboxone, Subutex, Sublocade) is a partial opioid agonist that reduces cravings and withdrawal symptoms without producing the full effects of opioids. Its "ceiling effect" means taking more doesn't increase effects after a certain point, making it safer than full agonists. Available as sublingual films, tablets, or monthly injections, buprenorphine can be prescribed in office settings, making it accessible for many patients. Learn more about Suboxone treatment.
Methadone is a full opioid agonist that prevents withdrawal and reduces cravings when taken at proper doses. It has a long history (since 1972) and strong evidence base. Methadone must be dispensed at certified Opioid Treatment Programs (OTPs), typically requiring daily clinic visits initially. Learn more about methadone treatment.
Naltrexone (Vivitrol) is an opioid antagonist that blocks opioid effects entirely. Available as daily oral tablets or monthly injections, naltrexone requires complete detoxification before starting (7-14 days opioid-free). It has no abuse potential and can be prescribed in any medical setting. Learn more about Vivitrol treatment.
Alcohol Medications
Naltrexone (ReVia, Vivitrol) reduces the rewarding effects of alcohol and decreases cravings. It can be taken as a daily pill or monthly injection and is often used with "targeted" dosing—taking it before situations where drinking is likely.
Acamprosate (Campral) helps restore balance to brain systems disrupted by chronic alcohol use. It's most effective for maintaining abstinence in people who have already stopped drinking and works well combined with counseling and support groups.
Disulfiram (Antabuse) creates an unpleasant reaction when alcohol is consumed, including nausea, headache, and flushing. This aversive approach works best for highly motivated patients and often in supervised settings where medication compliance can be verified.
How MAT Works in Addiction Treatment
MAT is most effective when it combines medication with comprehensive behavioral treatment. This includes individual counseling, group therapy, and support for issues like housing, employment, and family relationships.
The Treatment Process
Treatment typically begins with an assessment to determine the right medication and dosage. For buprenorphine, patients must be in mild-to-moderate withdrawal before starting (to avoid precipitated withdrawal). Methadone can be started immediately. Naltrexone requires complete detoxification first.
Once stabilized on medication, patients engage in ongoing counseling—typically Cognitive Behavioral Therapy (CBT) and/or Motivational Interviewing—to address the psychological aspects of addiction and build coping skills.
Benefits of Medication-Assisted Treatment
Research consistently shows that MAT improves outcomes across multiple measures:
- 50% or greater reduction in overdose deaths compared to abstinence-only treatment
- Improved treatment retention—patients stay in treatment longer and are more likely to complete
- Reduced illicit drug use—70% or greater reduction in opioid use
- Decreased criminal activity—less drug-seeking behavior and related crime
- Better employment outcomes—more patients able to maintain jobs
- Reduced HIV/Hepatitis C transmission—less injection drug use
- Improved birth outcomes—for pregnant women with OUD
Debunking MAT Myths
Despite overwhelming evidence, MAT remains underutilized due to persistent myths and stigma. Here are the facts:
Myth Busting
"MAT is just replacing one addiction with another." This is the most common misconception. Addiction is characterized by compulsive use despite negative consequences. MAT medications, taken as prescribed, do not produce euphoria or impair function. They normalize brain chemistry, allowing patients to work, care for families, and rebuild their lives.
"You're not really sober on MAT." The medical community and major recovery organizations recognize that taking prescribed medication for a medical condition is not the same as active addiction. Many MAT patients are active members of 12-step programs and other recovery communities.
"MAT should only be short-term." Research shows that longer treatment duration correlates with better outcomes. Stopping MAT prematurely is associated with high relapse rates and increased overdose risk. Many patients benefit from indefinite maintenance, similar to taking medication for any chronic condition.
Who Benefits from MAT?
MAT is recommended for anyone diagnosed with opioid use disorder (OUD) or alcohol use disorder (AUD) who meets clinical criteria. However, certain groups see particularly strong outcomes with medication-assisted treatment:
- People with moderate-to-severe opioid use disorder — including those addicted to heroin, fentanyl, or prescription painkillers. MAT is the first-line recommended treatment for OUD
- Individuals who have relapsed after abstinence-based treatment — research shows that adding medication significantly reduces relapse rates compared to behavioral treatment alone
- People at high risk of overdose — especially those returning to use after a period of abstinence (such as after incarceration or detox), when tolerance is low and overdose risk peaks
- Pregnant women with opioid addiction — buprenorphine or methadone is the standard of care during pregnancy, protecting both mother and baby from the dangers of withdrawal and continued use
- People with co-occurring mental health conditions — MAT stabilizes brain chemistry, allowing patients to engage more effectively in therapy for depression, anxiety, PTSD, and other conditions
- Those struggling with alcohol dependence — naltrexone and acamprosate help reduce cravings and maintain sobriety, especially when combined with counseling
There is no "typical" MAT patient. People of all ages, backgrounds, and addiction severities benefit. The decision to start MAT should be made collaboratively between you and your treatment provider, based on your medical history, substance use patterns, and personal goals.
MAT at Different Levels of Care
One of MAT's greatest strengths is its flexibility — medications can be incorporated into virtually every level of addiction treatment, providing continuity of care as patients progress through recovery:
- Medical Detox — Buprenorphine or methadone is often used during detoxification to manage opioid withdrawal safely and comfortably. This is frequently the first point where patients begin MAT
- Residential/Inpatient Treatment — Many residential programs now incorporate MAT, allowing patients to stabilize on medication while receiving intensive therapy. This combination addresses both the physical and psychological aspects of addiction simultaneously
- Partial Hospitalization (PHP) — Patients attend structured treatment during the day while continuing MAT. This level is ideal for patients stepping down from residential care who still need significant support
- Intensive Outpatient (IOP) — MAT paired with IOP provides flexibility for patients who need to maintain work or family responsibilities. Patients typically attend treatment sessions several times per week while continuing their medication
- Standard Outpatient — The most common long-term setting for MAT, with regular provider visits (often monthly once stabilized) combined with ongoing counseling. Suboxone and Vivitrol are particularly suited to this level
- Telehealth — Since regulatory changes in 2023, buprenorphine can be prescribed via telehealth without requiring an in-person visit first, dramatically expanding access for patients in rural areas or those with transportation barriers
The key principle is continuity — patients should continue MAT as they transition between levels of care. Interrupting medication during transitions is one of the leading causes of relapse and overdose. A good treatment program will ensure seamless medication management at every step.
Need Help Finding the Right Treatment?
Browse our directory or call to discuss treatment options.
Find Medication-Assisted Treatment Treatment Centers
Frequently Asked Questions About Medication-Assisted Treatment
Resources & Further Reading
Take the Next Step Toward Recovery
Search 2,700+ treatment centers across the Southeast offering medication-assisted treatment and find a program that fits your needs, location, and insurance.